Benzinga | Jun 21, 2021 09:20AM EDT

B of A Securities Initiates Coverage On Singular Genomics Systems with Neutral Rating, Announces Price Target of $26

B of A Securities analyst Michael Ryskin initiates coverage on Singular Genomics Systems (NASDAQ:OMIC) with a Neutral rating and announces Price Target of $26.